Market overview
The global hospital pharmacy market is worth USD 509 bn in 2026 and is forecast to reach USD 937 bn by 2036, growing at a 6.3% CAGR. United States is the largest country market and Inpatient dispensing is the largest by service segment.
| Scope | Drugs, compounding, dispensing and clinical pharmacy services supplied by pharmacies inside hospitals and health systems, measured at point of dispensing. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 480 bn |
| Value 2026 | USD 509 bn |
| Value 2036 | USD 937 bn |
| CAGR 2026-2036 | 6.3% |
| Volume 2026 | 7,239 million prescriptions |
| Volume 2036 | 10,418 million prescriptions |
| Average price 2026 | USD 70.3 per prescription |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Hospital Pharmacy market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 509 bn |
| 2027 | USD 541 bn |
| 2028 | USD 575 bn |
| 2029 | USD 611 bn |
| 2030 | USD 650 bn |
| 2031 | USD 691 bn |
| 2032 | USD 734 bn |
| 2033 | USD 780 bn |
| 2034 | USD 829 bn |
| 2035 | USD 882 bn |
| 2036 | USD 937 bn |
Hospital Pharmacy market segmentation
By service
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Inpatient dispensing | 46.0% | 42.3% | USD 234 bn | 5.4% |
| Outpatient and specialty dispensing | 30.0% | 33.3% | USD 153 bn | 7.4% |
| Sterile compounding and infusion | 14.0% | 14.8% | USD 71.2 bn | 6.9% |
| Clinical pharmacy services | 10.0% | 9.6% | USD 50.9 bn | 5.9% |
By drug class
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Oncology and specialty drugs | 34.0% | 38.8% | USD 173 bn | 7.7% |
| Anti-infectives | 14.0% | 11.5% | USD 71.2 bn | 4.2% |
| Cardiovascular and metabolic | 16.0% | 14.4% | USD 81.4 bn | 5.2% |
| Biologics and vaccines | 18.0% | 20.5% | USD 91.6 bn | 7.7% |
| Other | 18.0% | 14.8% | USD 91.6 bn | 4.2% |
By hospital size
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Small hospitals | 26.0% | 24.0% | USD 132 bn | 5.5% |
| Mid-sized hospitals | 38.0% | 37.0% | USD 193 bn | 6.0% |
| Large hospitals | 36.0% | 39.0% | USD 183 bn | 7.2% |
By automation level
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Manual | 42.0% | 32.0% | USD 214 bn | 3.5% |
| Semi-automated | 36.0% | 38.0% | USD 183 bn | 6.9% |
| Robotic and fully automated | 22.0% | 30.0% | USD 112 bn | 9.7% |
By ownership
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Public | 48.0% | 46.0% | USD 244 bn | 5.8% |
| Private for-profit | 32.0% | 34.0% | USD 163 bn | 7.0% |
| Non-profit and faith-based | 20.0% | 20.0% | USD 102 bn | 6.3% |
Top 25 countries for hospital pharmacy by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 85.5% of 2026 revenue and the 25 countries below together hold 96.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 214 bn | 42.0% | USD 390 bn | 6.2% |
| 2 | China | USD 71.2 bn | 14.0% | USD 157 bn | 8.2% |
| 3 | Japan | USD 35.6 bn | 7.0% | USD 51.6 bn | 3.8% |
| 4 | Germany | USD 25.4 bn | 5.0% | USD 40.3 bn | 4.7% |
| 5 | France | USD 17.8 bn | 3.5% | USD 27.2 bn | 4.3% |
| 6 | United Kingdom | USD 17.8 bn | 3.5% | USD 30.0 bn | 5.3% |
| 7 | Italy | USD 15.3 bn | 3.0% | USD 23.4 bn | 4.4% |
| 8 | Brazil | USD 12.7 bn | 2.5% | USD 26.2 bn | 7.5% |
| 9 | India | USD 12.7 bn | 2.5% | USD 33.7 bn | 10.2% |
| 10 | Canada | USD 12.7 bn | 2.5% | USD 21.6 bn | 5.4% |
| 11 | South Korea | USD 6.1 bn | 1.2% | USD 10.6 bn | 5.8% |
| 12 | Spain | USD 5.3 bn | 1.0% | USD 9.3 bn | 5.8% |
| 13 | Australia | USD 5.3 bn | 1.0% | USD 9.3 bn | 5.8% |
| 14 | Mexico | USD 4.5 bn | 0.9% | USD 9.9 bn | 8.2% |
| 15 | Russia | USD 4.5 bn | 0.9% | USD 8.0 bn | 5.8% |
| 16 | Turkey | USD 3.8 bn | 0.8% | USD 8.2 bn | 8.0% |
| 17 | Netherlands | USD 3.1 bn | 0.6% | USD 5.2 bn | 5.6% |
| 18 | Saudi Arabia | USD 3.1 bn | 0.6% | USD 6.7 bn | 8.1% |
| 19 | Indonesia | USD 3.1 bn | 0.6% | USD 8.0 bn | 10.1% |
| 20 | Taiwan | USD 3.1 bn | 0.6% | USD 5.2 bn | 5.6% |
| 21 | Poland | USD 2.3 bn | 0.5% | USD 3.9 bn | 5.6% |
| 22 | Switzerland | USD 2.3 bn | 0.5% | USD 3.9 bn | 5.6% |
| 23 | Belgium | USD 2.3 bn | 0.5% | USD 3.9 bn | 5.6% |
| 24 | Argentina | USD 2.3 bn | 0.5% | USD 3.9 bn | 5.6% |
| 25 | Egypt | USD 2.3 bn | 0.5% | USD 5.0 bn | 8.1% |
| Rest of world | USD 20.6 bn | 4.0% | USD 35.7 bn | 5.7% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- McKesson
- Cardinal Health
- Cencora
- Omnicell
Group 2: Regional and specialist players
- Becton Dickinson
- Swisslog Healthcare
- Sinopharm
- ScriptPro
- Yuyama
- Fagron Sterile Services
- QuVa Pharma
- SCA Pharma
Group 3: Emerging and niche players
- ARxIUM
- Willach Group
- Leiters Health
- Pearson Medical Technologies
- Capsa Healthcare
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the hospital pharmacy market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.3% is calculated from the resulting values.
The market is divided by service, by drug class, by hospital size, by automation level, by ownership. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the hospital pharmacy market?
The global hospital pharmacy market is estimated at USD 480 bn in 2025 and USD 509 bn in 2026.
How fast will the hospital pharmacy market grow?
It is forecast to reach USD 937 bn by 2036, a compound annual growth rate of 6.3% from 2026, an increase of USD 429 bn.
Which country is the largest market for hospital pharmacy?
United States is the largest market by revenue at USD 214 bn in 2026, 42.0% of the global total. The three largest countries together hold 63.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.2% a year from 2026 to 2036.
Which hospital pharmacy segment is largest?
In the by service split, Inpatient dispensing is the largest segment with 46.0% of 2026 revenue.
Who are the leading hospital pharmacy companies?
Global leaders include McKesson, Cardinal Health, Cencora, Omnicell.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- BiologicsUSD 508 bn · 8.0% CAGR
- Mental Health ServicesUSD 511 bn · 6.0% CAGR
- NutraceuticalUSD 516 bn · 7.5% CAGR
- Specialty PharmacyUSD 523 bn · 8.5% CAGR
- Generic DrugsUSD 462 bn · 5.0% CAGR
- Sterile InjectableUSD 454 bn · 8.5% CAGR
- TabletUSD 580 bn · 5.5% CAGR
- Home HealthcareUSD 410 bn · 8.0% CAGR
← Hospital Capacity Management Solutions Hospital Supplies →